Drug Shortage Report for COMBIVENT UDV
Report ID | 2178 |
Drug Identification Number | 02231675 |
Brand name | COMBIVENT UDV |
Common or Proper name | COMBIVENT UDV |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | IPRATROPIUM BROMIDE SALBUTAMOL |
Strength(s) | 0.2MG 1.0MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION |
Packaging size | 20 x 2.5ml |
ATC code | R03AL |
ATC description | ADRENERGICS, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-01-11 |
Estimated end date | 2017-04-24 |
Actual end date | 2017-04-05 |
Shortage status | Resolved |
Updated date | 2017-04-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2017-04-06 | English | Compare |
v7 | 2017-04-05 | French | Compare |
v6 | 2017-04-05 | English | Compare |
v5 | 2017-04-05 | French | Compare |
v4 | 2017-04-05 | English | Compare |
v3 | 2017-03-14 | French | Compare |
v2 | 2017-03-14 | English | Compare |
v1 | 2017-03-14 | English | Compare |
Showing 1 to 8 of 8